Impact of ERAS approach and minimally-invasive techniques on outcome of patients undergoing liver surgery for hepatocellular carcinoma

Francesca Ratti, Federica Cipriani, Raffaella Reineke, Marco Catena, Laura Comotti, Luigi Beretta, Luca Aldrighetti

Research output: Contribution to journalArticle

Abstract

Background and aim Aim of the study was to assess the impact of ERAS approach (“fluid restrictive and drainless”) on open liver resections for HCC comparing their outcome with open resections in pre-ERAS period and with laparoscopic surgery. Study design 207 patients undergoing minor liver resection for HCC were divided into three groups: Group A, open minor resections in pre-ERAS period (95 patients); Group B, laparoscopic ERAS resections (55 patients); Group C, open ERAS resections (57 patients). Results Blood loss was lower in group C and B compared with group A. Postoperative morbidity was 26.5% in group A, 16.3% in group B and 12.1% in group C (p <0.05). Ascites was less frequent in group B (7.5%) and C (6.2%) compared with group A (12%). Median time for functional recovery in group B (3 days) and C (3 days) was shorter compared with group A (5 days). Conclusions Laparoscopic approach confirms to be associated with reduced blood loss and postoperative morbidity. In patients who cannot be candidates to minimally-invasive approach, ERAS management seems to allow blood loss and postoperative morbidity reduction: indeed, results achieved in this group of patients are more similar to those of laparoscopy than to pre-ERAS open surgery.
Original languageEnglish
Pages (from-to)1243 - 1248
Number of pages6
JournalDigestive and Liver Disease
Volume48
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

Keywords

  • ERAS
  • Fast track
  • Hepatocellular carcinoma
  • Laparoscopy
  • Liver failure
  • Liver surgery

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Impact of ERAS approach and minimally-invasive techniques on outcome of patients undergoing liver surgery for hepatocellular carcinoma'. Together they form a unique fingerprint.

  • Cite this